Self-Emulsifying Formulations to Increase the Oral Bioavailability of 4,6,4'-Trimethylangelicin as a Possible Treatment for Cystic Fibrosis.

Franceschinis, Erica; Roverso, Marco; Gabbia, Daniela; De Martin, Sara; Brusegan, Matteo; Vaccarin, Christian; Bogialli, Sara; Chilin, Adriana

Franceschinis, Erica; Roverso, Marco; Gabbia, Daniela; De Martin, Sara; Brusegan, Matteo; Vaccarin, Christian; Bogialli, Sara; Chilin, Adriana.

Afiliación

Franceschinis E; Department of Pharmaceutical and Pharmacological Sciences, Via Marzolo 5, 35131 Padua, Italy.
Roverso M; Department of Chemical Sciences, Via Marzolo 1, 35131 Padua, Italy.
Gabbia D; Department of Pharmaceutical and Pharmacological Sciences, Via Marzolo 5, 35131 Padua, Italy.
De Martin S; Department of Pharmaceutical and Pharmacological Sciences, Via Marzolo 5, 35131 Padua, Italy.
Brusegan M; Department of Pharmaceutical and Pharmacological Sciences, Via Marzolo 5, 35131 Padua, Italy.
Vaccarin C; Department of Pharmaceutical and Pharmacological Sciences, Via Marzolo 5, 35131 Padua, Italy.
Bogialli S; Center for Radiopharmaceutical Sciences ETH-PSI-USZ, Paul Scherrer Institute, 5232 Villigen, Switzerland.
Chilin A; Department of Chemical Sciences, Via Marzolo 1, 35131 Padua, Italy.

Pharmaceutics ; 14(9)2022 Aug 27.

Article en En | MEDLINE | ID: mdl-36145554

Palabras clave

SEDDS; TMA; cystic fibrosis; oral bioavailability

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Pharmaceutics Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google